HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roccisana, J. Articles by Garcia-Ocaña, A. Search for Related Content PubMed PubMed Citation Articles by Roccisana, J. Articles by Garcia-Ocaña, A. Social Bookmarking                What's this?

Targeted Inactivation of Hepatocyte Growth Factor Receptor c-met in ß-Cells Leads to Defective Insulin Secretion and GLUT-2 Downregulation Without Alteration of ß-Cell Mass

¹ Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
² Vanderbilt University Medical Center, Nashville, Tennessee

Overexpression of hepatocyte growth factor (HGF) in the ß-cell of transgenic mice enhances ß-cell proliferation, survival, and function. In the current studies, we have used conditional ablation of the c-met gene to uncover the physiological role of HGF in ß-cell growth and function. Mice in which c-met is inactivated in the ß-cell (MetCKO mice) display normal body weight, blood glucose, and plasma insulin compared with control littermates. In contrast, MetCKO mice displayed significantly diminished glucose tolerance and reduced plasma insulin after a glucose challenge in vivo. This impaired glucose tolerance in MetCKO mice was not caused by insulin resistance because sensitivity to exogenous insulin was similar in both groups. Importantly, in vitro glucose-stimulated insulin secretion in MetCKO islets was decreased by 50% at high glucose concentrations compared with control islets. Furthermore, whereas insulin and glucokinase expression in MetCKO islets were normal, GLUT-2 expression was decreased by 50%. These changes in ß-cell function in MetCKO mice were not accompanied by changes in total ß-cell mass, islet morphology, islet cell composition, and ß-cell proliferation. Interestingly, however, MetCKO mice display an increased number of small islets, mainly single and doublet ß-cells. We conclude that HGF/c-met signaling in the ß-cell is not essential for ß-cell growth, but it is essential for normal glucose-dependent insulin secretion.

Abbreviations: BrdU, 5-bromo-2'-deoxyuridine; GLP-1, glucagon-like peptide 1; GSIS, glucose-stimulated insulin secretion; HGF, hepatocyte growth factor; hGH, human growth hormone; KRBB, Krebs-Ringer bicarbonate buffer; RIA, radioimmunoassay; TGF-, transforming growth factor-

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Yano, Z. Liu, J. Donovan, M. K. Thomas, and J. F. Habener Stromal Cell Derived Factor-1 (SDF-1)/CXCL12 Attenuates Diabetes in Mice and Promotes Pancreatic {beta}-Cell Survival by Activation of the Prosurvival Kinase Akt Diabetes, December 1, 2007; 56(12): 2946 - 2957. [Abstract] [Full Text] [PDF]

				R. C. Vasavada, L. Wang, Y. Fujinaka, K. K. Takane, T. C. Rosa, J. M.D. Mellado-Gil, P. A. Friedman, and A. Garcia-Ocana Protein Kinase C-{zeta} Activation Markedly Enhances {beta}-Cell Proliferation: An Essential Role in Growth Factor Mediated {beta}-Cell Mitogenesis Diabetes, November 1, 2007; 56(11): 2732 - 2743. [Abstract] [Full Text] [PDF]

				A. Bertola, S. Bonnafous, M. Cormont, R. Anty, J.-F. Tanti, A. Tran, Y. Le Marchand-Brustel, and P. Gual Hepatocyte Growth Factor Induces Glucose Uptake in 3T3-L1 Adipocytes through A Gab1/Phosphatidylinositol 3-Kinase/Glut4 Pathway J. Biol. Chem., April 6, 2007; 282(14): 10325 - 10332. [Abstract] [Full Text] [PDF]

				A. M Ackermann and M. Gannon Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion J. Mol. Endocrinol., February 1, 2007; 38(2): 193 - 206. [Abstract] [Full Text] [PDF]

				C. Santangelo, P. Matarrese, R. Masella, M. C. Di Carlo, A. Di Lillo, B. Scazzocchio, E. Vecci, W. Malorni, R. Perfetti, and E. Anastasi Hepatocyte growth factor protects rat RINm5F cell line against free fatty acid-induced apoptosis by counteracting oxidative stress J. Mol. Endocrinol., January 1, 2007; 38(1): 147 - 158. [Abstract] [Full Text] [PDF]

				R. C. Vasavada, I. Cozar-Castellano, D. Sipula, and A. F. Stewart Tissue-Specific Deletion of the Retinoblastoma Protein in the Pancreatic {beta}-Cell Has Limited Effects on {beta}-Cell Replication, Mass, and Function Diabetes, January 1, 2007; 56(1): 57 - 64. [Abstract] [Full Text] [PDF]

				M. Johansson, G. Mattsson, A. Andersson, L. Jansson, and P.-O. Carlsson Islet Endothelial Cells and Pancreatic {beta}-Cell Proliferation: Studies in Vitro and during Pregnancy in Adult Rats Endocrinology, May 1, 2006; 147(5): 2315 - 2324. [Abstract] [Full Text] [PDF]